Cytokine antibody arrays in biomarker discovery and validation

Current Proteomics

Volumn 9, Issue 1, 2012, Pages 55-70

  Huang, Ruo Pan ^a,b   Burkholder, Brett ^a   Jones, Valerie Sloane ^a   Jiang, Wei Dong ^a   Mao, Ying Qing ^a   Chen, Qiao Lin ^a,b   Shi, Zhi ^a,b  

^a RayBiotech   (United States)

^b South China Biochip Research Center   (China)

Author keywords

Antibody arrays; Biomarker; Cytokine; Protein arrays

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CA 125 ANTIGEN; CXCL16 CHEMOKINE; CYTOKINE ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANTIBODY DETECTION; ANTIBODY LABELING; ANTIINFLAMMATORY ACTIVITY; ASTHMA; AUTISM; AUTOIMMUNE DISEASE; CROHN DISEASE; CYTOKINE ANTIBODY ARRAY; DEGENERATIVE DISEASE; DISEASE MARKER; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN MICROARRAY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS; WESTERN BLOTTING;

EID: 84858318563     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016412799746209     Document Type: Review

References (130)

1. Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352, 1685-1695.
2. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 1995, 13, 251-276.
3. Van, P.L. and Abbas, A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science, 1998, 280, 243-248.
4. Moser, B.; Wolf, M.; Walz, A. and Loetscher, P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol., 2004, 25, 75-84.
5. Engelhardt, E.; Toksoy, A.; Goebeler, M.; Debus, S.; Brocker, E.B. and Gillitzer, R. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phasespecific infiltration of leukocyte subsets in human wound healing. Am. J. Pathol., 1998, 153, 1849-1860.
6. Belperio, J.A.; Keane, M.P.; Arenberg, D.A.; Addison, C.L.; Ehlert, J.E.; Burdick, M.D. and Strieter, R.M. CXC chemokines in angiogenesis. J. Leukoc. Biol., 2000, 68, 1-8.
7. MacDougald, O.A. and Mandrup, S. Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab., 2002, 13, 5-11.
8. Janes, K.A.; Albeck, J.G.; Gaudet, S.; Sorger, P.K.; Lauffenburger, D.A. and Yaffe, M.B. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science, 2005, 310, 1646-1653.
9. Werner, S. and Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev., 2003, 83, 835-870.
10. Schluns, K.S. and Lefrancois, L. Cytokine control of memory Tcell development and survival. Nat. Rev. Immunol., 2003, 3, 269-279.
11. Parrish-Novak, J.; Dillon, S.R.; Nelson, A.; Hammond, A.; Sprecher, C.; Gross, J.A.; Johnston, J.; Madden, K.; Xu, W.; West, J.; Schrader, S.; Burkhead, S.; Heipel, M.; Brandt, C.; Kuijper, J.L.; Kramer, J.; Conklin, D.; Presnell, S.R.; Berry, J.; Shiota, F.; Bort, S.; Hambly, K.; Mudri, S.; Clegg, C.; Moore, M.; Grant, F.J.; Lofton-Day, C.; Gilbert, T.; Rayond, F.; Ching, A.; Yao, L.; Smith, D.; Webster, P.; Whitmore, T.; Maurer, M.; Kaushansky, K.; Holly, R.D. and Foster, D. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature, 2000, 408, 57-63.
12. Majka, M.; Janowska-Wieczorek, A.; Ratajczak, J.; Ehrenman, K.; Pietrzkowski, Z.; Kowalska, M.A.; Gewirtz, A.M.; Emerson, S.G. and Ratajczak, M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood, 2001, 97, 3075-3085.
13. Goldring, M.B. and Goldring, S.R. Cytokines and cell growth control. Crit. Rev. Eukaryot. Gene Expr., 1991, 1, 301-326.
14. Mantovani, A.; Allavena, P.; Sica, A. and Balkwill, F. Cancerrelated inflammation. Nature, 2008, 454, 436-444.
15. Joyce, J.A. and Pollard, J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer, 2009, 9, 239-252.
16. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L.; Finch, C.E.; Frautschy, S.; Griffin, W.S.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L.; Mrak, R.; Mackenzie, I.R.; McGeer, P.L.; O'Banion, M.K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; Van Muiswinkel, F.L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G. and Wyss-Coray, T. Inflammation and Alzheimer's disease. Neurobiol. Aging, 2000, 21, 383-421.
17. Hirsch, E.C. and Hunot, S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol., 2009, 8, 382-397.
18. Wellen, K.E. and Hotamisligil, G.S. Inflammation, stress, and diabetes. J. Clin. Invest., 2005, 115, 1111-1119.
19. Ross, J.S. and Fletcher, J.A. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells, 1998, 16, 413-428.
20. Mendelsohn, J. and Baselga, J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol., 2003, 21, 2787-2799.
21. Feldmann, M. and Maini, R.N. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med., 2003, 9, 1245-1250.
22. Hoofnagle, J.H. Therapy of acute and chronic viral hepatitis. Adv. Intern. Med., 1994, 39, 241-275.
23. Lane, H.C.; Kovacs, J.A.; Feinberg, J.; Herpin, B.; Davey, V.; Walker, R.; Deyton, L.; Metcalf, J.A.; Baseler, M. and Salzman, N. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet, 1988, 2, 1218-1222.
24. Goodin, D.S.; Frohman, E.M.; Garmany, G.P. Jr.; Halper, J.; Likosky, W.H.; Lublin, F.D.; Silberberg, D.H.; Stuart, W.H. and van den, N.S. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology, 2002, 58, 169-178.
25. Ozaki, K. and Leonard, W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem., 2002, 277, 29355-29358.
26. Hirano, T.; Taga, T.; Nakano, N.; Yasukawa, K.; Kashiwamura, S.; Shimizu, K.; Nakajima, K.; Pyun, K.H. and Kishimoto, T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA, 1985, 82, 5490-5494.
27. Kishimoto, T.; Akira, S.; Narazaki, M. and Taga, T. Interleukin-6 family of cytokines and gp130. Blood, 1995, 86, 1243-1254.
28. Audet, J. Adventures in time and space: Nonlinearity and complexity of cytokine effects on stem cell fate decisions. Biotechnol. Bioeng., 2010, 106, 173-182.
29. Snijders, A.; Kalinski, P.; Hilkens, C.M. and Kapsenberg, M.L. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol., 1998, 10, 1593-1598.
30. Heaney, M.L. and Golde, D.W. Soluble cytokine receptors. Blood, 1996, 87, 847-857.
31. Hsu, H.Y.; Wittemann, S. and Joos, T.O. Miniaturized parallelized sandwich immunoassays. Methods Mol. Biol., 2008, 428, 247-261.
32. Kusnezow, W.; Banzon, V.; Schroder, C.; Schaal, R.; Hoheisel, J.D.; Ruffer, S.; Luft, P.; Duschl, A. and Syagailo, Y.V. Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics, 2007, 7, 1786-1799.
33. Huang, R.; Jiang, W.; Yang, J.; Mao, Y.Q.; Zhang, Y.; Yang, W.; Yang, D.; Burkholder, B.; Huang, R.F. and Huang, R.P. A biotin label-based antibody array for high-content profiling of protein expression. Cancer Genom. Proteomics, 2010, 7, 129-141.
34. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; Friedman, L.F.; Galasko, D.R.; Jutel, M.; Karydas, A.; Kaye, J.A.; Leszek, J.; Miller, B.L.; Minthon, L.; Quinn, J.F.; Rabinovici, G.D.; Robinson, W.H.; Sabbagh, M.N.; So, Y.T.; Sparks, D.L.; Tabaton, M.; Tinklenberg, J.; Yesavage, J.A.; Tibshirani, R. and Wyss-Coray, T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med., 2007, 13, 1359-1362.
35. Spisak, S.; Tulassay, Z.; Molnar, B. and Guttman, A. Protein microchips in biomedicine and biomarker discovery. Electrophoresis, 2007, 28, 4261-4273.
36. Chandra, H. and Reddy, P.J. and Srivastava, S. Protein microarrays and novel detection platforms. Expert. Rev. Proteomics, 2011, 8, 61-79.
37. Wingren, C. and Borrebaeck, C.A. Antibody-based microarrays. Methods Mol. Biol., 2009, 509, 57-84.
38. Chandra, H. and Reddy, P.J. and Srivastava, S. Protein microarrays and novel detection platforms. Expert. Rev. Proteomics, 2011, 8, 61-79.
39. Kingsmore, S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov., 2006, 5, 310-320.
40. Borrebaeck, C.A. and Wingren, C. High-throughput proteomics using antibody microarrays: an update. Expert. Rev. Mol. Diagn., 2007, 7, 673-686.
41. Alhamdani, M.S.; Schroder, C. and Hoheisel, J.D. Oncoproteomic profiling with antibody microarrays. Genome Med., 2009, 1, 68.
42. Ayoglu, B.; Haggmark, A.; Neiman, M.; Igel, U.; Uhlen, M.; Schwenk, J.M. and Nilsson, P. Systematic antibody and antigenbased proteomic profiling with microarrays. Expert. Rev. Mol. Diagn., 2011, 11, 219-234.
43. Borrebaeck, C.A. and Wingren, C. Design of high-density antibody microarrays for disease proteomics: Key technological issues. J. Proteomics, 2009, 72, 928-935.
44. Dexlin, L.; Ingvarsson, J.; Frendeus, B.; Borrebaeck, C.A. and Wingren, C. Design of recombinant antibody microarrays for cell surface membrane proteomics. J. Proteome. Res., 2008, 7, 319-327.
45. Kwong, K.Y.; Baskar, S.; Zhang, H.; Mackall, C.L. and Rader, C. Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity. J. Mol. Biol., 2008, 384, 1143-1156.
46. Pansri, P.; Jaruseranee, N.; Rangnoi, K.; Kristensen, P. and Yamabhai, M. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol., 2009, 9, 6.
47. Anderson, N.L. and Anderson, N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics, 2002, 1, 845-867.
48. Hotta, K.; Funahashi, T.; Arita, Y.; Takahashi, M.; Matsuda, M.; Okamoto, Y.; Iwahashi, H.; Kuriyama, H.; Ouchi, N.; Maeda, K.; Nishida, M.; Kihara, S.; Sakai, N.; Nakajima, T.; Hasegawa, K.; Muraguchi, M.; Ohmoto, Y.; Nakamura, T.; Yamashita, S.; Hanafusa, T. and Matsuzawa, Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1595-1599.
49. Chandra, H.; Reddy, P.J. and Srivastava, S. Protein microarrays and novel detection platforms. Expert. Rev. Proteomics, 2011, 8, 61-79.
50. Ray, S.; Mehta, G. and Srivastava, S. Label-free detection techniques for protein microarrays: prospects, merits and challenges. Proteomics, 2010, 10, 731-748.
51. MacBeath, G. and Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination [see comments]. Science, 2000, 289, 1760-1763.
52. Vargas, D.L.; Nascimbene, C.; Krishnan, C.; Zimmerman, A.W. and Pardo, C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol., 2004, 57, 67-81.
53. Ray, S.; Britschgi, M.; Herbert, C.; Takeda-Uchimura, Y.; Boxer, A.; Blennow, K.; Friedman, L.F.; Galasko, D.R.; Jutel, M.; Karydas, A.; Kaye, J.A.; Leszek, J.; Miller, B.L.; Minthon, L.; Quinn, J.F.; Rabinovici, G.D.; Robinson, W.H.; Sabbagh, M.N.; So, Y.T.; Sparks, D.L.; Tabaton, M.; Tinklenberg, J.; Yesavage, J.A.; Tibshirani, R. and Wyss-Coray, T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med., 2007, 13, 1359-1362.
54. Jensen, S.S. and Gad, M. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J. Inflamm.(Lond)., 2010, 7, 37.
55. Kunz, M. and Ibrahim, S.M. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators. Inflamm., 2009, 2009, 979258.
56. Bauer, J.W.; Baechler, E.C.; Petri, M.; Batliwalla, F.M.; Crawford, D.; Ortmann, W.A.; Espe, K.J.; Li, W.; Patel, D.D.; Gregersen, P.K. and Behrens, T.W. Elevated serum levels of interferonregulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS. Med., 2006, 3, e491.
57. Hueber, W.; Tomooka, B.H.; Zhao, X.; Kidd, B.A.; Drijfhout, J.W.; Fries, J.F.; van Venrooij, W.J.; Metzger, A.L.; Genovese, M.C. and Robinson, W.H. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis., 2007, 66, 712-719.
58. Raza, K.; Falciani, F.; Curnow, S.J.; Ross, E.J.; Lee, C.Y.; Akbar, A.N.; Lord, J.M.; Gordon, C.; Buckley, C.D. and Salmon, M. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther., 2005, 7, R784-R795.
59. Fiorino, G.; Rovida, S.; Correale, C.; Malesci, A. and Danese, S. Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? Curr. Drug Targets, 2010, 11, 249-260.
60. Kader, H.A.; Tchernev, V.T.; Satyaraj, E.; Lejnine, S.; Kotler, G.; Kingsmore, S.F. and Patel, D.D. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am. J. Gastroenterol., 2005, 100, 414-423.
61. Kato, K.; Fukunaga, K.; Kamikozuru, K.; Kashiwamura, S.; Hida, N.; Ohda, Y.; Takeda, N.; Yoshida, K.; Iimuro, M.; Yokoyama, Y.; Kikuyama, R.; Miwa, H. and Matsumoto, T. Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naive patients with Crohn's disease. Gut. Liver, 2011, 5, 37-45.
62. Meeker, R.B.; Poulton, W.; Markovic-Plese, S.; Hall, C. and Robertson, K. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. J. Neurovirol., 2011, 17, 258-273.
63. Paczesny, S.; Krijanovski, O.I.; Braun, T.M.; Choi, S.W.; Clouthier, S.G.; Kuick, R.; Misek, D.E.; Cooke, K.R.; Kitko, C.L.; Weyand, A.; Bickley, D.; Jones, D.; Whitfield, J.; Reddy, P.; Levine, J.E.; Hanash, S.M. and Ferrara, J.L. A biomarker panel for acute graft-versus-host disease. Blood, 2009, 113, 273-278.
64. Wadsworth, S.; Sin, D. and Dorscheid, D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J. Asthma Allergy, 2011, 4, 77-86.
65. Patil, S.P.; Wisnivesky, J.P.; Busse, P.J.; Halm, E.A. and Li, X.M. Detection of immunological biomarkers correlated with asthma control and quality of life measurements in sera from chronic asthmatic patients. Ann. Allergy Asthma Immunol., 2011, 106, 205-213.
66. Kim, H.B.; Kim, C.K.; Iijima, K.; Kobayashi, T. and Kita, H. Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest, 2009, 135, 295-302.
67. Matsunaga, K.; Yanagisawa, S.; Ichikawa, T.; Ueshima, K.; Akamatsu, K.; Hirano, T.; Nakanishi, M.; Yamagata, T.; Minakata, Y. and Ichinose, M. Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J. Allergy Clin. Immunol., 2006, 118, 84-90.
68. Ichikawa, T.; Matsunaga, K.; Minakata, Y.; Yanagisawa, S.; Ueshima, K.; Akamatsu, K.; Hirano, T.; Nakanishi, M.; Sugiura, H.; Yamagata, T. and Ichinose, M. Possible impact of salivary influence on cytokine analysis in exhaled breath condensate. Anal. Chem. Insights, 2007, 2, 85-92.
69. Matsunaga, K.; Yanagisawa, S.; Ichikawa, T.; Akamatsu, K.; Koarai, A.; Hirano, T.; Sugiura, H.; Minakata, Y. and Ichinose, M. Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy. Allergol. Int., 2009, 58, 89-96.
70. Huang, R.P. An array of possibilities in cancer research using cytokine antibody arrays. Expert. Rev. Proteomics, 2007, 4, 299-308.
71. Huang, R.P.; Yang, W.; Yang, D.; Flowers, L.; Horowitz, I.R.; Cao, X. and Huang, R. The promise of cytokine antibody arrays in the drug discovery process. Expert. Opin. Ther. Targets, 2005, 9, 601-615.
72. Yeretssian, G.; Lecocq, M.; Lebon, G.; Hurst, H.C. and Sakanyan, V. Competition on nitrocellulose-immobilized antibody arrays: from bacterial protein binding assay to protein profiling in breast cancer cells. Mol. Cell Proteomics, 2005, 4, 605-617.
73. Hudelist, G.; Pacher-Zavisin, M.; Singer, C.F.; Holper, T.; Kubista, E.; Schreiber, M.; Manavi, M.; Bilban, M. and Czerwenka, K. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat., 2004, 86, 281-291.
74. Vazquez-Martin, A.; Colomer, R. and Menendez, J.A. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Eur. J. Cancer, 2007, 43, 1117-1124.
75. Lowe, K.A.; Shah, C.; Wallace, E.; Anderson, G.; Paley, P.; McIntosh, M.; Andersen, M.R.; Scholler, N.; Bergan, L.; Thorpe, J.; Urban, N. and Drescher, C.W. Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 2480-2487.
76. Jacobs, I.J. and Menon, U. Progress and challenges in screening for early detection of ovarian cancer. Mol. Cell Proteomics, 2004, 3, 355-366.
77. Toh, H.C.; Wang, W.W.; Chia, W.K.; Kvistborg, P.; Sun, L.; Teo, K.; Phoon, Y.P.; Soe, Y.; Tan, S.H.; Hee, S.W.; Foo, K.F.; Ong, S.; Koo, W.H.; Zocca, M.B. and Claesson, M.H. Clinical benefit of allogeneic melanoma cell Lysate-Pulsed autologous dendritic cell vaccine in MAGE-positive colorectal cancer patients. Clin. Cancer Res., 2009, 15, 7726-7736.
78. Engwegen, J.Y.; Gast, M.C.; Schellens, J.H. and Beijnen, J.H. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci., 2006, 27, 251-259.
79. Huang, R.P.; Huang, R.; Fan, Y. and Lin, Y. Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal. Biochem., 2001, 294, 55-62.
80. Britschgi, M. and Wyss-Coray, T. Blood protein signature for the early diagnosis of Alzheimer disease. Arch. Neurol., 2009, 66,161-165.
81. Shafer, M.W.; Mangold, L.; Partin, A.W. and Haab, B.B. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate, 2007, 67, 255-267.
82. Srivastava, M.; Eidelman, O.; Jozwik, C.; Paweletz, C.; Huang, W.; Zeitlin, P.L. and Pollard, H.B. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Mol. Genet. Metab., 2006, 87, 303-310.
83. Kader, H.A.; Tchernev, V.T.; Satyaraj, E.; Lejnine, S.; Kotler, G.; Kingsmore, S.F. and Patel, D.D. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am. J. Gastroenterol., 2005, 100, 414-423.
84. Liu, B.C.; Zhang, L.; Lv, L.L.; Wang, Y.L.; Liu, D.G. and Zhang, X.L. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am. J. Nephrol., 2006, 26, 483-490.
85. Rovin, B.H.; Song, H.; Hebert, L.A.; Nadasdy, T.; Nadasdy, G.; Birmingham, D.J.; Yung, Y.C. and Nagaraja, H.N. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int., 2005, 68, 1825-1833.
86. Hu, H.; Kwun, J.; Aizenstein, B.D. and Knechtle, S.J.; Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation, 2009, 87, 1814-1820.
87. Paczesny, S.; Krijanovski, O.I.; Braun, T.M.; Choi, S.W.; Clouthier, S.G.; Kuick, R.; Misek, D.E.; Cooke, K.R.; Kitko, C.L.; Weyand, A.; Bickley, D.; Jones, D.; Whitfield, J.; Reddy, P.; Levine, J.E.; Hanash, S.M. and Ferrara, J.L. A biomarker panel for acute graft-versus-host disease. Blood, 2009, 113, 273-278.
88. Wu, J.Q.; Wang, B.; Belov, L.; Chrisp, J.; Learmont, J.; Dyer, W.B.; Zaunders, J.; Cunningham, A.L.; Dwyer, D.E. and Saksena, N.K. Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages. Retrovirology, 2007, 4, 83.
89. Bogatkevich, G.S.; Ludwicka-Bradley, A.; Highland, K.B.; Hant, F.; Nietert, P.J.; Singleton, C.B.; Feghali-Bostwick, C.A. and Silver, R.M. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum., 2007, 56, 2432-2442.
90. Sakai, A.; Ohshima, M.; Sugano, N.; Otsuka, K. and Ito, K. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J. Periodontol., 2006, 77, 856-864.
91. Andreas, K.; Lubke, C.; Haupl, T.; Dehne, T.; Morawietz, L.; Ringe, J.; Kaps, C. and Sittinger, M. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res. Ther., 2008, 10, R9.
92. Meeker, R.B.; Poulton, W.; Markovic-Plese, S.; Hall, C. and Robertson, K. Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection. J. Neurovirol., 2011, 17, 258-273.
93. Bafadhel, M.; Saha, S.; Siva, R.; McCormick, M.; Monteiro, W.; Rugman, P.; Dodson, P.; Pavord, I.D.; Newbold, P. and Brightling, C.E. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration, 2009, 78, 256-262.
94. Miller, M.; Cho, J.Y.; Pham, A.; Ramsdell, J. and Broide, D.H. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J. Immunol., 2009, 182, 684-691.
95. Leonardi, A.; Sathe, S.; Bortolotti, M.; Beaton, A. and Sack, R. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy, 2009, 64, 710-717.
96. Tadros, Y.; Ruiz-Deya, G.; Crawford, B.E.; Thomas, R. and Abdel-Mageed, A.B. In vivo proteomic analysis of cytokine expression in laser capture-microdissected urothelial cells of obstructed ureteropelvic junction procured by laparoscopic dismembered pyeloplasty. J. Endourol., 2003, 17, 333-336.
97. Reverter, J.L.; Nadal, J.; Fernández-Novell, J.M.; Ballester, J.; Ramio-Lluch, L.; Rivera, M.M.; Elizalde, J.; Abengoechea, S.; Guinovart, J.J. and Rodriguez-Gil, J.E. Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2009, 50, 1378-1382.
98. Kuusniemi, A.M.; Lapatto, R.; Holmberg, C.; Karikoski, R.; Rapola, J. and Jalanko, H. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int., 2005, 68,121-132.
99. Traktuev, D.O.; Merfeld-Clauss, S.; Li, J.; Kolonin, M.; Arap, W.; Pasqualini, R.; Johnstone, B.H. and March, K.L. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res., 2008, 102, 77-85.
100. Nichols, M.T.; Gidey, E.; Matzakos, T.; Dahl, R.; Stiegmann, G.; Shah, R.J.; Grantham, J.J.; Fitz, J.G. and Doctor, R.B. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology, 2004, 40, 836-846.
101. Walt, D.R.; Blicharz, T.M.; Hayman, R.B.; Rissin, D.M.; Bowden, M.; Siqueira, W.L.; Helmerhorst, E.J.; Grand-Pierre, N.; Oppenheim, F.G.; Bhatia, J.S.; Little, F.F. and Brody, J.S. Microsensor arrays for saliva diagnostics. Ann. N. Y. Acad. Sci., 2007, 1098, 389-400.
102. Celis, J.E.; Moreira, J.M.; Gromova, I.; Cabezon, T.; Ralfkiaer, U.; Guldberg, P.; Straten, P.T.; Mouridsen, H.; Friis, E.; Holm, D.; Rank, F. and Gromov, P. Towards discovery-driven translational research in breast cancer. FEBS J., 2005, 272, 2-15.
103. Liu, B.C.; Zhang, L.; Lv, L.L.; Wang, Y.L.; Liu, D.G. and Zhang, X.L. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am. J. Nephrol., 2006, 26, 483-490.
104. Hou, Z.; Sun, L.; Gao, L.; Liao, L.; Mao, Y. and Liu, J. Cytokine array analysis of peritoneal fluid between women with endometriosis of different stages and those without endometriosis. Biomarkers, 2009, 14, 604-618.
105. Lembo, A.J.; Neri, B.; Tolley, J.; Barken, D.; Carroll, S. and Pan, H. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Aliment. Pharmacol. Ther., 2009, 29, 834-842.
106. Sanchez-Carbayo, M.; Socci, N.D.; Lozano, J.J.; Haab, B.B. and Cordon-Cardo, C. Profiling bladder cancer using targeted antibody arrays. Am. J. Pathol., 2006, 168, 93-103.
107. Vazquez-Martin, A.; Colomer, R. and Menendez, J.A. Her-2/neuinduced "cytokine signature" in breast cancer. Adv. Exp. Med. Biol., 2008, 617, 311-319.
108. Sanchez-Carbayo, M. Dissecting cancer serum protein profiles using antibody arrays. Methods Mol. Biol., 2008, 428, 263-287.
109. Li, C.; Simeone, D.M.; Brenner, D.E.; Anderson, M.A.; Shedden, K.A.; Ruffin, M.T. and Lubman, D.M. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J. Proteome. Res., 2009, 8, 483-492.
110. Lukesova, S.; Kopecky, O.; Vroblova, V.; Hlavkova, D.; Andrys, C.; Moravek, P. and Cermakova, E. Determination of angiogenic factors in serum by protein array in patients with renal cell carcinoma. Folia Biol.(Praha)., 2008, 54, 134-140.
111. Huang, R.P. Cytokine antibody arrays: a promising tool to identify molecular targets for drug discovery. Comb. Chem. High Throughput. Screen., 2003, 6, 769-775.
112. Espina, V.; Woodhouse, E.C.; Wulfkuhle, J.; Asmussen, H.D.; Petricoin, E.F. III. and Liotta, L.A. Protein microarray detection strategies: focus on direct detection technologies. J. Immunol. Methods, 2004, 290,121-133.
113. Angenendt, P. Progress in protein and antibody microarray technology. Drug Discov. Today, 2005, 10, 503-511.
114. Ray, S.; Chandra, H. and Srivastava, S. Nanotechniques in proteomics: current status, promises and challenges. Biosens. Bioelectron., 2010, 25, 2389-2401.
115. Nelson, B.P.; Grimsrud, T.E.; Liles, M.R.; Goodman, R.M. and Corn, R.M. Surface plasmon resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA microarrays. Anal. Chem., 2001, 73, 1-7.
116. Pawlak, M.; Schick, E.; Bopp, M.A.; Schneider, M.J.; Oroszlan, P. and Ehrat, M. Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics, 2002, 2, 383-393.
117. Pei, R.; Cheng, Z.; Wang, E. and Yang, X. Amplification of antigen-antibody interactions based on biotin labeled proteinstreptavidin network complex using impedance spectroscopy. Biosens. Bioelectron., 2001, 16, 355-361.
118. Rickert, J.; Brecht, A. and Gopel, W. Quartz crystal microbalances for quantitative biosensing and characterizing protein multilayers. Biosens. Bioelectron., 1997, 12, 567-575.
119. Renken, J.; Dahint, R.; Grunze, M. and Josse, F. Multifrequency evaluation of different immunosorbents on acoustic plate mode sensors. Anal. Chem., 1996, 68, 176-182.
120. Nakanishi, K.; Ikebukuro, K. and Karube, I. Determination of cyanide using a microbial sensor. Appl. Biochem. Biotechnol., 1996, 60, 97-106.
121. Wu, G.; Ji, H.; Hansen, K.; Thundat, T.; Datar, R.; Cote, R.; Hagan, M.F.; Chakraborty, A.K. and Majumdar, A. Origin of nanomechanical cantilever motion generated from biomolecular interactions. Proc. Natl. Acad. Sci. USA, 2001, 98, 1560-1564.
122. Wu, G.; Datar, R.H.; Hansen, K.M.; Thundat, T.; Cote, R.J. and Majumdar, A. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat. Biotechnol., 2001, 19, 856-860.
123. Cui, Y.; Wei, Q.; Park, H. and Lieber, C.M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science, 2001, 293, 1289-1292.
124. Li, Y.; Yang, H.H.; You, Q.H.; Zhuang, Z.X. and Wang, X.R. Protein recognition via surface molecularly imprinted polymer nanowires. Anal. Chem., 2006, 78, 317-320.
125. Ma, C.; Fan, R.; Ahmad, H.; Shi, Q.; Comin-Anduix, B.; Chodon, T.; Koya, R.C.; Liu, C.C.; Kwong, G.A.; Radu, C.G.; Ribas, A. and Heath, J.R. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat. Med., 2011, 17, 738-743.
126. Gaster, R.S.; Hall, D.A.; Nielsen, C.H.; Osterfeld, S.J.; Yu, H.; Mach, K.E.; Wilson, R.J.; Murmann, B.; Liao, J.C.; Gambhir, S.S. and Wang, S.X. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med., 2009, 15, 1327-1332.
127. Lee, K.B.; Park, S.J.; Mirkin, C.A.; Smith, J.C. and Mrksich, M. Protein nanoarrays generated by dip-pen nanolithography. Science, 2002, 295, 1702-1705.
128. Blattler, T.; Huwiler, C.; Ochsner, M.; Stadler, B.; Solak, H.; Voros, J. and Grandin, H.M. Nanopatterns with biological functions. J. Nanosci. Nanotechnol., 2006, 6, 2237-2264.
129. Truskett, V.N. and Watts, M.P. Trends in imprint lithography for biological applications. Trends Biotechnol., 2006, 24, 312-317.
130. Kumar, N. and Hahm, J.I. Nanoscale protein patterning using selfassembled diblock copolymers. Langmuir, 2005, 21, 6652-6655.